2022 In Review

With the JP Morgan update season about to get in full swing, I thought it might be a good time to review the sequencing field and where we stand at the beginning of 2023. The big news was, of course, that after years of having a virtual monopoly, Illumina faces a bevy of new competitors....

2020 Sequencing Predictions

Here’s my take on what we might see in 2020 for the sequencing platform market. This isn’t specifically about JPM, but I wanted to get this out ahead of the conference since it’s obviously one of the main venues for “big announcements”.         Illumina 1) Merger/long reads I was all prepared to...

Illumina – PacBio Acquisition Poll

I'm running a quick poll to gauge the sequencing community's opinion about Illumina's proposed acquisition of PacBio. Just two simple questions. For the record, my answers are "yes" and "yes" (but I'm less confident about the second question). Check out my previous post to see my reasoning.

Scroll to top